`
`Inventors: SCHWARZ et al.
`
`Confirmation No.: 9244
`
`Applicant: BTL Medical Technologies S.R.O.
`
`Art Unit: 1629
`
`Application No.: 16/674,144
`
`Examiner: To Be Assigned
`
`Filing Date: November5, 2019
`
`Atty. Docket: 4387.00400G0
`
`Title: AESTHETIC METHOD OF BIOLOGICAL STRUCTURE TREATMENTBY
`
`MAGNETIC FIELD
`
`Information Disclosure Statement
`
`Mail Stop Amendment
`
`Commissionerfor Patents
`PO Box 1450
`Alexandria, VA 22313-1450
`
`Commissioner:
`
`Listed on accompanying IDS Forms PTO/SB/08a equivalent and/or PTO/SB/08b equivalent
`
`are documents that may be considered material to the patentability of this application as defined in
`
`37 C.F.R. §1.56, and in compliance with the duty of disclosure requirements of 37 C.F.R. §§ 1.97
`
`and 1.98.
`
`Applicant haslisted publication dates on the attached IDS Forms based on information
`
`presently available to the undersigned. However,the listed publication dates should not be
`
`construed as an admission that the information wasactually published on the date indicated.
`
`Applicant reserves the right to establish the patentability of the claimed invention over any
`
`of the information provided herewith, and/or to prove that this information maynotbe priorart,
`
`and/or to prove that this information may not be enabling for the teachings purportedly offered.
`
`
`
`-2-
`
`SCHWARZ et al.
`Application No. 16/674,144
`
`This statement should not be construed as a representation that a search has been made, or
`
`that information more material to the examination of the present patent application does not exist.
`
`The Examineris specifically requested not to rely solely on the material submitted herewith.
`
`Copies of documents FP13-FP66 and NPL80-NPL126 are submitted. However, in
`
`accordance with 37 C.F.R. § 1.98(a)(2)(—i1), no copies of U.S. patents and patent application
`
`publications cited as documents US1-US100 on the attached IDS Forms are submitted.
`
`Copies of documents FP1-FP12 and NPL1-NPL79 werecited by or submitted to the Office
`
`in an IDS that complies with 37 C.F.R. § 1.98(a)-(c) in Application No. 16/218,735, filed December
`
`13, 2018, which is relied upon for an earlierfiling date under 35 U.S.C. § 120. Thus, copies of these
`
`documents are not attached. 37 C.F.R. § 1.98(d).
`
`It is expected that the examiner will review the prosecution and cited art in the parent
`
`Application No(s). 16/218,735 in accordance with MPEP 2001.06(b), and indicate in the next
`
`communication from the office that the art cited in the earlier prosecution history has been reviewed
`
`in connection with the present application.
`
`It is respectfully requested that the Examinerinitial and return a copy of the enclosed IDS
`
`Forms, and indicate in the official file wrapper of this patent application that the documents have
`
`been considered.
`
`Atty. Dkt. No. 4387.00400G0
`
`
`
`-3-
`
`SCHWARZ et al.
`Application No. 16/674,144
`
`Respectfully submitted,
`
`STERNE, KESSLER, GOLDSTEIN & FOX P.L.L.C.
`
`JMO Cdk.
`
`Richard D. Coller III
`Attorney for Applicant
`Registration No. 60,390
`
`Date:
`
`January 27, 2020
`
`1100 New York Avenue, N.W.
`Washington, D.C. 20005-3934
`(202) 371-2600
`
`143260041
`
`Atty. Dkt. No. 4387.00400G0
`
`